V-SWITCH: A single-vector OFF-to-ON fluorescent reporter of live RNA virus infections

The paper introduces V-SWITCH, a highly modular, single-vector, OFF-to-ON fluorescent reporter system that utilizes a viral protease-mediated release-and-capture mechanism to enable robust, real-time detection of diverse RNA virus infections at single-cell resolution for applications ranging from host factor screening to antiviral drug discovery.

The Gist

Imagine you are trying to catch a spy (a virus) inside a crowded city (your body's cells). The problem is, the spy wears a disguise, and by the time you see the damage they've done, it's often too late. Scientists have been looking for a way to spot these spies the moment they start their work, without breaking the city apart to look for them.

This paper introduces V-SWITCH, a brilliant new "smart alarm system" that turns on a bright light the instant a virus starts infecting a cell.

Here is how it works, broken down into simple concepts:

1. The Broken Flashlight (The "OFF" State)

Think of a flashlight that has been snapped in half.

• The Top Half: This piece is glued to the wall of a room (the cell's "ER" or storage area). It can't move.
• The Bottom Half: This piece is floating freely in the center of the room (the nucleus), but it's too small to light up on its own.
• The Result: Because the two halves are separated, the flashlight is OFF. The cell looks dark and normal.

2. The Secret Cut (The Virus Arrives)

Viruses are like master locksmiths. To make copies of themselves, they use a special pair of scissors (a viral protease) to cut through the cell's defenses.

• In the V-SWITCH system, the scientists placed a "trap" right where the virus's scissors like to cut.
• When the virus enters and starts working, it accidentally cuts the string holding the Top Half of the flashlight to the wall.

3. The Snap-Back (The "ON" State)

Once the Top Half is cut loose, it is free to swim over to the center of the room where the Bottom Half is waiting.

• The Magic: As soon as the two halves touch, they snap back together perfectly.
• The Light: Suddenly, the flashlight turns ON and glows bright green.
• The Signal: A dark cell instantly becomes a glowing green cell. You now know, with 100% certainty, that a virus is inside and active.

Why is this a Big Deal?

1. It's a "Single-Vector" Kit (The Swiss Army Knife)
Older systems were like building a custom house for every single virus you wanted to study. If you wanted to study Dengue, you built one house. If you wanted Zika, you had to build a whole new one.
V-SWITCH is like a Lego set. The scientists built one main frame, and they can easily swap out the "scissors trap" part.

• Want to catch Dengue? Swap in the Dengue trap.
• Want to catch Zika? Swap in the Zika trap.
• Want to catch the Coronavirus? Swap in the Coronavirus trap.
  It's fast, cheap, and easy to change.

2. It Works in Real-Time (The Live Camera)
Because the light turns on inside the living cell, scientists can watch the infection happen in real-time. They can see exactly when a cell gets infected and how fast the virus spreads. It's like having a security camera that only turns on when a burglar breaks in, rather than checking the cameras after the fact.

3. It Helps Find Cures (The Drug Tester)
This system is a game-changer for finding new medicines.

• Scientists can add a potential drug to the glowing cells.
• If the drug works, the virus can't cut the trap, the flashlight stays OFF, and the cell remains dark.
• If the drug doesn't work, the cell glows green.
  This allows them to test thousands of drugs very quickly to see which ones stop the virus.

4. It Works on "Normal" Cells
Many virus studies use cancer cells because they are easy to grow. But drugs that work on cancer cells might be toxic to normal, healthy cells. V-SWITCH works great in normal, healthy human cells (like skin cells), giving scientists a more realistic picture of how a drug would work in a real human body.

The Bottom Line

V-SWITCH is a modular, high-tech "light switch" for viruses. It turns a dark, invisible infection into a bright, visible signal. This helps scientists:

• Spot infections instantly.
• Track how viruses spread from cell to cell.
• Test new drugs to stop them.
• Adapt quickly to new viral threats.

It's a powerful new tool that makes the invisible world of viral infections visible, helping us fight back faster and smarter.

Technical Summary

1. Problem Statement

Developing robust, versatile, and non-perturbative reporter systems for monitoring live viral infections remains a central challenge in virology. Existing solutions face significant limitations:

• Viral Genome Engineering: Inserting fluorescent proteins directly into viral genomes (e.g., GFP-labeled Dengue or Zika) often imposes a fitness cost, altering replication kinetics and genetic stability, which hinders comparative studies and large-scale screening.
• Host-Encoded Limitations: Previous "switch-based" biosensors (e.g., FlipGFP) often rely on protease overexpression or non-replicating surrogates, lacking sensitivity at physiological protease levels during authentic infection.
• Readout Constraints: Some translocation-based reporters rely on signal redistribution rather than intensity changes, making them incompatible with high-throughput flow cytometry or bulk plate assays.
• Adaptability: Many systems require complex genome editing (CRISPR knock-ins) for each new cell line or virus, limiting rapid deployment.

There is a critical need for a single-vector, host-encoded, OFF-to-ON reporter that detects viral protease activity with high sensitivity, allows for single-cell resolution, and is easily adaptable across diverse viruses and cell types.

2. Methodology

The authors developed V-SWITCH, a modular, single-vector split-fluorescent reporter system based on a "release-and-capture" mechanism.

• Molecular Design:
  • Split-mNeonGreen (mNG) System: Utilizes the mNG3A(1-10) and mNG(11) fragments.
  • Cleavable Anchor Module (CAM): The mNG(1-10) fragment is fused to a Nuclear Localization Signal (NLS), a virus-specific Protease Cleavage Site (PCS), and a Sec61 transmembrane domain (anchoring it to the Endoplasmic Reticulum). It is expressed under the EF1α promoter.
  • Nuclear Capture Module (NCM): The mNG(11) fragment is fused to TagBFP (for stability and nuclear segmentation) and constitutively expressed in the nucleus under the CMV promoter.
  • Mechanism: In the uninfected state, the CAM is sequestered at the ER, keeping the cell "OFF" (dark). Upon infection, the viral protease cleaves the PCS, releasing the NLS-mNG(1-10) fragment. This fragment translocates to the nucleus, where it complements the nuclear mNG(11)-BFP, reconstituting the fluorescent mNG signal ("ON" state).
• Modularity: Each functional module (splitFP, PCS, anchor, antibiotic resistance) is flanked by unique restriction sites, allowing rapid swapping of components to target different viruses.
• Validation Models:
  • Viruses: Dengue Virus (DENV), Zika Virus (ZIKV), West Nile Virus (WNV), and Human Coronavirus OC43 (OC43).
  • Cell Lines: A549 (lung carcinoma), BJ-5α (normal fibroblasts), HEK293T, and HeLa.
  • Assays: Flow cytometry, live-cell time-lapse imaging, siRNA-mediated gene silencing, and antiviral compound screening (MK0608, Niclosamide, HA15, Ferrostatin-1).

3. Key Contributions

• Single-Vector Architecture: Unlike the first-generation system requiring CRISPR knock-in of the NCM into endogenous loci (NPM1 or HNRNPC), V-SWITCH expresses both modules from a single lentiviral vector. This eliminates the need for genome editing, enabling rapid deployment in any cell line.
• High Sensitivity & Specificity: The system achieves a true OFF-to-ON switch with minimal background noise. It correlates >93% with viral protein staining (NS3/NS2B/E) across various MOIs.
• Built-in Controls: The inclusion of constitutive TagBFP serves three purposes:
  1. Stabilizes the small mNG(11) peptide.
  2. Acts as an expression control to gate out cells that failed to express the reporter.
  3. Provides a nuclear channel for automated image segmentation.
• Broad Adaptability: Demonstrated successful reprogramming for four distinct viruses across two viral families (Flaviviridae and Coronaviridae) by simply swapping the PCS cassette.

4. Key Results

• Detection Accuracy: In A549 cells infected with DENV, V-SWITCH activation showed 93.5–99.7% concordance with NS3 immunofluorescence. Background fluorescence in uninfected cells was negligible (<4.5%).
• Antiviral Screening: The reporter accurately quantified the efficacy of known inhibitors.
  • MK0608 (RdRp inhibitor): IC50 values of ~7.5–13.6 µM.
  • Niclosamide (Endosomal acidification inhibitor): IC50 values of ~1.6–3.5 µM.
  • HA15 (BiP/GRP78 inhibitor): Showed 70% reduction in DENV infection in normal BJ-5α fibroblasts without cytotoxicity, validating the system's utility in non-cancerous lines.
• Host Factor Identification: siRNA knockdown of host factors RACK1 and EMC6 significantly reduced DENV reporter activation (85–88% reduction). Interestingly, EMC6 silencing enhanced ZIKV infection in A549 cells, highlighting cell-type or strain-specific dependencies.
• Single-Cell Heterogeneity: Live-cell imaging revealed that infection kinetics are heterogeneous. Cells were categorized into "low," "average," and "high" activators based on mNG/BFP ratios.
  • Correlation: Higher mNG signal intensity correlated positively with higher intracellular viral RNA levels (validated by FACS sorting and RT-qPCR), proving the signal reflects genuine replication heterogeneity rather than technical noise.
• Cross-Virus Validation:
  • ZIKV & WNV: Showed similar dose-dependent inhibition by MK0608 and Niclosamide.
  • OC43: Successfully detected Coronavirus infection and response to Ferrostatin-1 (a ferroptosis inhibitor).

5. Significance

• Accelerated Antiviral Discovery: V-SWITCH provides a scalable, antibody-free platform for high-throughput screening of antiviral compounds and host-directed therapies across multiple viruses and physiologically relevant cell types (including normal fibroblasts).
• Mechanistic Virology: The ability to physically separate infected from uninfected cells via FACS (based on fluorescence) without fixation or staining enables downstream single-cell multi-omics (transcriptomics, CRISPR screens) to dissect host-pathogen interactions.
• Resolution of Infection Dynamics: The system captures the temporal heterogeneity of viral replication at the single-cell level, offering insights into stochastic infection outcomes that bulk assays miss.
• Accessibility: The single-vector design and streamlined cloning strategy lower the barrier to entry, allowing laboratories to rapidly customize the reporter for emerging pathogens with known protease cleavage sites.

In summary, V-SWITCH represents a significant advancement in viral reporter technology, moving from complex, virus-engineered, or genome-edited systems to a flexible, host-encoded, single-vector solution that is highly sensitive, quantitative, and broadly applicable.